Norland's X-ray device will assess fracture risk:
This article was originally published in Clinica
Executive Summary
Norland Medical Systems has received 510(k) clearance from the FDA to market a fracture risk assessment feature on its Apollo DXA peripheral bone densitometer. Until recently, doctors could not easily predict which osteoporosis sufferers were at high risk of a bone fracture, but last year the FDA determined that manufacturers of bone density devices could offer a feature which would help. This feature is already available on Norland's pDEXA device.
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.